US FDA proposes a new rule to simplify drug manufacturer registration, improve supply chain transparency and strengthen oversight of global pharmaceutical networks.
The proposal also strengthens registration requirements for certain foreign facilities producing drugs and active pharmaceutical ingredients, giving the FDA greater visibility into upstream supply chains.
| Photo Credit:
Dado Ruvic
The U.S. FDA on Friday proposed a rule
to streamline registration requirements for certain drug
In an initiative to increase the efficiency of drug manufacturing in the United States, the FDA has
The U.S. Food and Drug Administration announced Thursday it is launching "FDA PreCheck" in order to help construct drug…
New rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. …
FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after receiving more than 80…
Centre proposes easier drug import approvals for testing and research, aiming to reduce compliance burden and strengthen…
New initiative aims to shorten timelines from early-stage research to late-stage clinical trials through regulatory reforms.
